Can specialized HIV community pharmacies improve treatment?

©2012 Mary Ann Liebert Inc., publishers

Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized Walgreen pharmacies across the U.S. had significantly greater adherence to and persistence with their therapeutic drug regimens according to a study published in AIDS Patient Care and STDs.

Patricia Murphy, MPH and coauthors from Walgreen Co. and University of California San Francisco School of Pharmacy compared therapeutic anti- adherence (the degree to which patients follow their prescribed drug regimen) and persistence (the time to treatment discontinuation) for HIV/AIDS patients who used HIV-specialized pharmacies or traditional community pharmacies during the time span of a year. The study, "Impact of HIV Specialized Pharmacies on Adherence and Persistence with Antiretroviral Therapy," followed patients in nine cities across seven states. The researchers propose that their results should demonstrate the value of implementing policies to encourage the use of specialized HIV pharmacies for filling antiviral prescriptions.

"While antiretroviral treatments have dramatically increased the health and life expectancy of people infected with HIV, and helped to slow HIV transmission, these medications only work if taken on a regular basis," says Editor-in-Chief Jeffrey Laurence, MD, Director of the Laboratory for Research at Weill Medical College of Cornell University, New York, NY. "Enlisting pharmacies in a multi-pronged approach to maintaining is critical. This study demonstrates the role of the pharmacist in this important endeavor."

More information: The article is available free on the AIDS Patient Care and STDs website at http://www.liebertpub.com/apc.

add to favorites email to friend print save as pdf

Related Stories

Are there gender differences in anti-HIV drug efficacy?

Aug 09, 2012

Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration ...

Recommended for you

Condoms 'too small' for Uganda men

Sep 19, 2014

Ugandan MPs have been inundated with complaints that many condoms on sale in the east African nation are too small, warning the problem is a blow to the fight against AIDS.

Withdrawal from the evolutionary race

Sep 18, 2014

In some HIV sufferers, the immune system does not fight off the immune deficiency virus. Instead, the body tolerates the pathogen. A research team headed by ETH Zurich has now determined how strongly patients ...

The genetics of coping with HIV

Sep 16, 2014

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

User comments